phendimetrazine

phendimetrazine
Clinical data
Trade names	Bontril
Other names	Mephenmetrazine; (2S,3S)-3,4-Dimethyl-2-phenylmorpholine
AHFS/Drugs.com	Monograph
Routes of; administration	Oral administration
ATC code	none;
Legal status
Legal status	BR: Class B2 (Anorectic drugs); CA: Schedule IV; DE: Anlage II (Authorized trade only, not prescriptible); US: Schedule III;
Pharmacokinetic data
Bioavailability	Peak plasma levels occur within 1 to 3 hours. Absorption is usually complete by 4 to 6 hours
Metabolism	Liver
Elimination half-life	19-24 hours
Excretion	Urinary elimination
Identifiers
	IUPAC name 3,4-dimethyl-2-phenylmorpholine;
CAS Number	634-03-7 ;
PubChem CID	30487;
DrugBank	DB01579 ;
ChemSpider	28295 ;
UNII	AB2794W8KV;
KEGG	D08347 ;
ChEMBL	ChEMBL1615439 ;
Chemical and physical data
Formula	C12H17NO
Molar mass	191.274 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@H]1[C@@H](OCCN1C)C2=CC=CC=C2;
	InChI InChI=1S/C12H17NO/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3/t10-,12+/m0/s1 ; Key:MFOCDFTXLCYLKU-CMPLNLGQSA-N ;
	(verify)